Funding · Company
Areteia Therapeutics, Inc.
Chapel Hill, NCBiotech & Pharma
Areteia Therapeutics, Inc. of Chapel Hill, NC has disclosed $360M across 1 Form D offering filed with the SEC on Feb 21, 2025.
$360M
Total disclosed
1
Form D offering
2022
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$360M
Form D · Feb 21, 2025 ↗
Q1 2025
· 2 amendments, first filed Jul 14, 2022
· target $445M
Filing details
HeadquartersChapel Hill, NCIndustryBiotech & Pharma (Biotechnology)Incorporated2022SEC CIK0001937542Offerings on file1
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →